Lack of knowledge, misinformation, and social stigma about opioids are some of the major barriers to their effective use in...
CFTR modulator registered by the TGA Trikafta has been registered by the TGA for the treatment of cystic fibrosis in...
Patients with severe asthma experience significant improvements in quality-of-life and participation in life with add-on monoclonal antibody therapies but there’s...
Lung transplantation is a feasible option for COVID-19 patients with irreversible lung injury but should be reserved for carefully selected...
Inhaled budesonide can reduce the likelihood of requiring urgent medical care for a COVID-19 infection, and can shorten recovery time...
TSANZ welcomes new CEO Internationally renowned respiratory physiologist Dr. Graham Hall takes up the position after former incumbent Tanya Buchanan...
Lockdown has led to dramatic drop in bacterial pneumonia Social distancing measures introduced to stave off COVID-19 infection have dramatically...
The Australasian Sleep Association has updated its consensus statement on the safe use of respiratory therapy and NIV to minimise...
Pirfenidone yielded improved outcome over placebo in a trial of patients with progressive fibrotic interstitial lung diseases other than idiopathic...
People with cystic fibrosis have a high prevalence of asymptomatic carriage of toxigenic C. difficile, an Australian study has shown. However,...